EIF3C抗体

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P09959(EIF3C Antibody) at dilution 1/20. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P09959(EIF3C Antibody) at dilution 1/20. (Original magnification: ×200)    

  
  

**Background of EIF3C Antibody**

Eukaryotic Initiation Factor 3 subunit C (EIF3C) is a critical component of the eukaryotic translation initiation factor 3 (EIF3) complex, which plays a central role in initiating protein synthesis by recruiting ribosomes to mRNA. The EIF3 complex, composed of 13 subunits (EIF3A-EIF3M), regulates the assembly of the 43S pre-initiation complex and ensures accurate start codon selection. EIF3C, encoded by the *EIF3C* gene, directly interacts with the 40S ribosomal subunit and other initiation factors, facilitating mRNA scanning and stabilizing translation machinery.

EIF3C antibodies are essential tools for studying translation regulation, cellular proliferation, and disease mechanisms. Dysregulation of EIF3C has been linked to cancers, viral infections, and developmental disorders, as its overexpression or mutations can disrupt translational fidelity, promoting oncogenesis or viral replication. Researchers use EIF3C-specific antibodies in techniques like Western blotting, immunoprecipitation, and immunofluorescence to quantify protein expression, map interactions, or localize EIF3C within cellular compartments.

These antibodies also aid in exploring post-translational modifications of EIF3C, such as phosphorylation, which may modulate its function in stress responses or cell cycle progression. However, challenges remain in ensuring antibody specificity due to structural similarities among EIF3 subunits. Validated EIF3C antibodies are crucial for elucidating its role in translational control and its potential as a therapeutic target in diseases characterized by aberrant protein synthesis.